FindTrial
Sign In

Canceled by the investigator The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)

The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030782
Enrollment
Unknown
Registered
2020-03-14
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:none

Sponsors

Cangzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 89 Years

Inclusion criteria

Inclusion criteria: New Coronavirus Patients Meeting the Criteria for the Diagnosis and Treatment of New Coronavirus Infected Pneumonia (Trial Version 5)

Exclusion criteria

Exclusion criteria: Pregnant woman

Design outcomes

Primary

MeasureTime frame
28-day prognosis;—

Contacts

Public ContactLihui Wang

Cangzhou People's Hospital

849614995@qq.com+86 13832102657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026